" " J Neur N'surg Psych 1996;61:634-637 Aug 96 " " Mov Disord 1997;12:103-106 Feb 97 " " Ann Neur 1997;42:245-248 Sep 97 " " Neur 1997;49:438-444 Oct 97 " " Ann Neur 1997;42:349-355 Oct 97 " " Clin Neuropharm 1997;20:394-401 Dec 97 " " Clin Neuropharm 1997;20:409-418 Dec 97 " ethylester Ann Neur 1996;39:400-404 Apr 96 " metabolism Ann Neur 1997;42:300-304 Oct 97 " strategy Ann Neur 1995;38:389-395 Oct 95 " " J Neur N'surg Psych 1995;59:555 Dec 95 " " Neur 1996;47:Supp 3 Feb 97 " " Neur 1997;49:711-713 Oct 97 " toxicity Mov Disord 1997;12:634-638 Nov 97 Lewy body disease J Neur N'surg Psych 1996;60:531-538 Jun 96 " Neur 1996;47:462-466 Sep 96 " Neur 1997;48:376-380 Mar 97 " Science News 18 Oct 1997:255 Nov 97 Liquid Sinemet Neur 1996;47:1493-1495 Feb 97 Locus coeruleus Brain 1995;118:131-143 Jun 95 Machado-Joseph Ann Neur 1995;38:684-687 Nov 95 Macrophage Science News 21 Sep 96:180 Oct 96 Magnetic stimulation Brain 1996;119:71-77 May 96 " Brain 1996;119:815-822 Sep 96 " Ann Neur 1996;40:344-355 Oct 96 " Brain 1997;120:1587-1602 Nov 97 MAO inhibition, effect J Neurosci 1997;17:2267-2272 May 97 MAO-B Neur 1996;46:1262-1269 Jun 96 " Ann Neur 1996;40:99-107 Aug 96 Markers, neurochemical Neur 1996;47:718-726 Oct 96 " " Mov Disord 1997;12:167-174 May 97 " " Ann Neur 1997;41;530-539 May 97 Melatonin BMJ 18 May 96:1242-43 Jun 96 " , antioxidant J Neurosci 1997;17:1683-1690 Apr 97 Memory, Hippocampus Science News 7 Sep 1996:150 Oct 96 Memory and PD Science 6 Sep 96:1263-64 Oct 96 " Science 6 Sep 96:1399-02 Oct 96 " J Neur N'surg Psych 1997;62:410-413 Jun 97 Menstrual effects Neur 1995;45:1028 Jul 95 " Mov Disord 1993;8:240-241 Nov 95 Metaclopramide (Reglan)JAMA 1995;274:1780-82 Jan 96 Metals, exposure to Neur 1997;48:650-658 Apr 97 Methylsalsolinol Ann Neur 1996;40:119-122 Aug 96 Metronome Lancet 11 May 1996:1337 Jun 96 Migraine, DA and Clin Neuropharm 1997;20:36-41 May 97 Mimics of PD Arch Neur 1995;58:294-298 Oct 95 " Brain 1995;118:951-958 Oct 95 " BMJ 16 Mar 1996:724 Apr 96 Mitochondria Science News 5 Aug 1995;84 Sep 95 " Neur 1995;45:2097-2099 Feb 96 " Mov Disord 1997;12:3-16 Feb 97 " Mov Disord 1997;12:639-645 Nov 97 Mortality J Neur N'surg Psych 1995;58:293-299 Apr 95 " Arch Neur 1997;54:260-264 Apr 97 Motor cognition Brain 1997;120:1339-53 Oct 97 " " Brain 1997;120:1355-75 Oct 97 " fluctuations J Neur N'surg Psych 1996;61:634-637 Aug 96 " skill learning Brain 1997;120:1325-37 Oct 97 Movement, head and eye Ann Neur 1996;39:749-760 Jul 96 " , coordinated Brain 1997;120:91-102 Apr 97 " , " Brain 1997;120:593-604 Jun 97 " , " Brain 1997;120:963-976 Aug 97 " , " Mov Disord 1997;12:665-676 Nov 97 " , " Mov Disord 1997;12:646-654 Nov 97 " , " Brain 1997;120:2093-111 Dec 97 " , diagnostic Arch Neur 1997;54:450-454 May 97 " , guidance Brain 1997;120:977-990 Aug 97 MPTP Ann Neur 1994;36:765-770 Dec 94 " J Neurosci 1996;16:7776-7782 Jan 97 " Neur 1996;47:Supp 3 Feb 97 Multiple System AtrophyAnn Neur 1995;37:204-210 Mar 95 " J Neur N'surg Psych 1995;59:144-151 Sep 95 " Clin Neuropharm 1997;20:239-244 Sep 97 Muscle, sound from Lancet 22 Feb 97;533-535 Apr 97 Nerve Growth Factor J Neurosurg 1996;84:685-689 Apr 96 " J Neurosci 1996;16:5437-5442 Nov 96 " J Neurosci 1996;16:6433-6442 Nov 96 " J Neurosurg 1997;86:511-518 Jul 97 " and diabetes Lancet 19 Oct 96:1044-45 Nov 96 Neuroleptics (risk) J Neur N'surg Psych 1996;60:213-216 Mar 96 Neuropeptides Brain 1996;119:823-830 Sep 96 Neurosciences Inst. Science 27 Oct 1995:572 Dec 95 Neurotrophic factors Ann Neur 1996;40:346 Oct 96 " problems Nat Med 1997;3:497 Jul 97 " (BDNF) J Neurosci 1997;17:2295-2313 May 97 Neurotrophic (GDNF) WSJ 21 Mar 1996: Apr 96 " N Neurosci 1996;16:8132-8139 Jan 97 NMDA antagonist J Neurosci 1996;16:4231-39 Nov 96 " J Neurosci 1997;17:2921-2927 May 97 Nurr-1 Science 11 Apr 97:248-50 May 97 " , editorial Science 11 Apr 97:202 May 97 Nutrients and PD Neur 1996;47:644-650 Oct 96 Olfaction and PD J Neur N'surg Psych 1997;62:436-446 Jul 97 Ondansetron (Zofran) Neur 1995;45:1305-1308 Oct 95 " Neur 1996;47:1608-1609 Feb 97 " , for tremor J Neur N'Surg Psych 1997;62:282-284 Apr 97 On-off effect J Neur N'surg Psych 1995;59:555 Dec 95 " J Neur N'surg Psych 1996;61:634-637 Aug 96 Onset, early vs late Mov Disord 1997;12:277-284 Aug 97 Oxidative stress Neur 1995;45S3:55 May 95 " J Neur N'surg Psych 1995;59:90-91 Aug 95 " Ann Neur 1996;39:378-381 Apr 96 Pallidopyramidal Ann Neur 1995;38:954-956 Feb 96 Pallidotomy, boom in WSJ 22 Feb 95:1 Mar 95 " , benefits Neur 1995;45:753-761 Jun 96 " , " Lancet 25 May 96;1490 Jul 96 " , " Ann Neur 1996;39:826 Jul 96 " , " J Neur N'surg Psych 1997;62:125-132 Apr 97 " , " Lancet 15 Mar 1997:777 Apr 97 " , " Neur 1997;48:1273-1277 Jun 97 " , " Ann Neur 1997;41:834 Jul 97 " , " Arch Neur 1997;54:1026-1029 Oct 97 " , " J Neurosurg 1997;87:358-367 Oct 97 " , " Neur 1997;49:1072-1077 Nov 97 " , cognition Arch Neur 1997;54:947-950 Sep 97 " and DBS Nat Med 1997;3:671-674 Jul 97 " " Nat Med 1997;3:602-603 Jul 97 " " Neur 1997;49;1078-1083 Nov 97 " , effects J Neur N'surg Psych 1997;63:150-162 Oct 97 " , gamma knife Ann Neur 1996;39:535-538 Jun 96 " , history Ann Neur 1996;40:341-343 Oct 96 " , low-cost Brain 1997;120:729-737 Jul 97 " , PET scan Ann Neur 1995;37:776-783 Jul 95 " , " Ann Neur 1996;39:450-459 Jun 96 " , " Brain 1997;120:1301-13 Oct 97 " , " Brain 1997;120:1315-24 Oct 97 " , success Ann Neur 1996;40:355-366 Oct 96 " , " Neur 1997;1083-1090 Nov 97 " , " Mov Disord 1997;12:752-755 Nov 97 " , technique J Neurosurg 1996;84:194-202 Jul 96 " , " J Neurosurg 1996;85:1005-1012 Jan 97 " , " J Neurosurg 1997:87:52-59 Aug 97 Paroxetine (Paxil) Neur 1994;44:2406 Jan 95 Pathways, neural Neur 1995;45S3:S28-S34 May 95 " Neur 1996;1032-1036 Nov 96 Perception, auditory Mov Disord 1997;12:655-664 Nov 97 " , visual Brain 1996;119:79-87 May 96 Pergolide (Permax) Neur 1995;45S3:S5 May 95 " Neur 1995;45S3:S13-S21 May 95 " Neur 1995;45S3:S22-S27 May 95 " Mov Disord 1997;12:402-407 Aug 97 Personality and PD Lancet 15 Feb 97:478 Mar 97 PET diagnosis Ann Neur 1994;36:759-764 Dec 94 " Ann Neur 1994;2:176-182 Dec 94 " J Neur N'surg Psych 1995;59:597-600 Jan 96 " Neur 1995;45:1995-2004 Feb 96 " Ann Neur 1996;39:450-459 Jun 96 " Neur 1996;46:1430-1436 Jun 96 " Neur 1996;46:1200-1205 Jun 96 " Ann Neur 1996;39:650-658 Jun 96 " Brain 1996;119:585-591 Jul 96 " Neur 1996;47:462-466 Sep 96 " Ann Neur 1996;40:873-884 Mar 97 " Ann Neur 1997;41:58-64 Mar 97 " scans, questioned Science 11 Apr 97:196-198 May 97 Pituitary, effects on Clin Neuropharm 1996;19(1):72-80 Dec 97 Porphyria and PD drugs J Neur N'surg Psych 1997;62:562 Jul 97 Post-encephalitis PD Ann Neur 1997;42:356-359 Oct 97 Pramipexole PDF Newsletter Spr 1996:1 Apr 96 " JAMA 9 Jul 87:125-130 Aug 97 " Neur 1997;49:162-168 Aug 97 " Neur 1997;49:724-728 Oct 97 " Neur 1997;49:1060-1065 Nov 97 Prevalence J Neur N'surg Psych 1997;62:10-15 Mar 97 Prions Science News 13 Apr 1996;228 May 96 Progenitor cells Eng. & Sci Sept 95:26 Nov 95 Progression (case hist)NEJM 1996;334:116-118 Feb 96 " JAMA 6 Mar 1996:716 Apr 96 " JAMA 9 Oct 1196;1171 Nov 96 " , in putamen Brain 1996;119:2097-103 Mar 97 Progressive Supranuc. J Neur N'surg Psych 1996;60:589 Jun 96 " J Neur N'surg Psych 1996;61:615-620 Aug 96 " Neur 1996;47:1-9 Sep 96 " Neur 1996;47:148-154 Sep 96 " Brain 1997;120:65-74 Apr 97 " Arch Neur 1997;54:1104-1108 Oct 97 Propranolol (Inderal) Neur 1996;46:1548-1551 Jul 96 Propath program Arch Neur 1996;53:881-884 Oct 96 Proton Magnetic Res. J Neur N'Surg Psych 1997;62:239-242 Apr 97 Prozac (fluoxetine) Neur 1995;45:1855-1858 Nov 95 Psychogenic PD Arch Neur 1995;52:802-810 Sep 95 Quality of life J Neur N'surg Psych 1996;61:71-74 Aug 96 Raclopride, in PET Mov Disord 1997;12:33-38 Feb 97 Rapid-onset Neur 1997;49:1066-1069 May 97 Rating scale, clinical Clin Neuropharm 1997;20:183-184 Sep 97 " " Clin Neuropharm 1997;20:322-327 Sep 97 Reaction time J Neur N'surg Psych 1995;59:499-506 Dec 95 " Brain 1996;119:1689-1704Jan 97 Reflex blink, and PD J Neurosci 1996;16:7308-7330 Dec 96 Regeneration, brain Lancet 16 Mar 1996:751 Apr 96 " Science News 21 Sep 1996:180 Oct 96 " Science 28 Feb 97;1318-19 Apr 97 " , spinal cord Lancet 21 Sep 1996:814 Oct 96 Registry (surveys) Neur 1995;45:1991-1995 Feb 96 " NEJM 1996;334:71-76 Feb 96 " Neur 1995;45:2143-2146 Feb 96 " Arch Neur 1996;53:66-71 Feb 96 Research priorities JAMA 25 Oct 95:1257-8 Nov 95 Response time, levodopaNeur 1996;46:1055-1058 Jun 96 " Neur 1996;46:1059-1062 Jun 96 Restless leg syndrome JAMA 17 Jan 1996: Feb 96 " Neur 1996;47:1435-1441 Feb 97 " Clin Neuropharm 1997;20:148-151 May 97 " Mov Disord 1997;12:402-407 Aug 97 Rigidity Mov Disord 1997;12:24-32 Feb 97 Risperidone Mov Disord 1997;12:119-121 Feb 97 " Mov Disord 1997;12:610-612 Sep 97 Ropinirole Neur 1997;49:393-399 Oct 97 Salsolinol Ann Neur 1996;40:119-122 Aug 96 Selegiline, amphetamineLancet 1995;346:64 Oct 95 " , and AD NEJM 14 Apr 97:1216-22 May 97 " , benefits Ann Neur 1995;37:95-98 Feb 95 " , " Mov Disord 1997;12:175-182 May 97 " , " Ann Neur 1997;41:833-834 Jul 97 " , DATATOP Arch Neur 1995;52:237-245 Apr 95 " , " Arch Neur 1995;52:564-570 Nov 95 " , " Ann Neur 1996;39:37-45 Mar 96 " , " Ann Neur 1996;39:29-36 Mar 96 " , dosage Mov Disord 1997;12:293-296 Aug 97 " , in favor of PDF Newsletter Spr 1996:2 Apr 96 " , PET scan Ann Neur 1994;36:759-764 Dec 94 " , pro and con BMJ 16 Mar 96:702-705 Apr 96 " , " " " Ann Neur 1996;40:266-269 Sep 96 " , " " " Ann Neur 1997;41:282-283 Mar 97 " , protection by Ann Neur 1995;38:771-777 Jan 96 " , " J Neurochem 1997;68:33-39 Aug 97 " , " J Neurochem 1997;68:434-436 Aug 97 " , risks of BMJ 16 Dec 95:1602-7 Jan 96 " , " Ann Neur 1996;40:841-845 Mar 97 " , " Neur 1997;48:662-667 Apr 97 " , " Clin Neuropharm 1997;20:276-278 Sep 97 " , " J Neur N'surg Psych 1997;63:228-234 Oct 97 ", special review Neur 1996;47:Supp 3 Feb 97 Serotonin agonist Neur 1997;49:1168-1170 Nov 97 " " Mov Disord 1997;12:756-759 Nov 97 " antagonist Clin Neuropharm 1997;20:300-310 Sep 97 " syndrome Neur 1997;48:1070-1077 Mar 97 Sertoli cells Nat Med 1997;3:1129-1132 Nov 97 Shy-Drager Ann Neur 1995;37:204-210 Mar 95 Sinemet, dissolved Mov Disord 1997;12:608-610 Sep 97 Sinemet CR J Neur N'surg Psych 1995;58:ad Jul 95 " Lancet 11 Nov 1995;1290 Dec 05 " Mov Disord 1997;12:677-681 Nov 97 Sjogren's syndrome Mov Disord 1997;12:121-123 Feb 97 Sleep, violence in Lancet 19 Apr 97;1150 Jun 97 " , benefit Mov Disord 1997;12:506-508 Sep 97 Smell, loss of J Neur N'surg Psych 1997;62:436-446 Jul 97 Smoking and PD Neur 1995;45:1041 Sep 95 " Neur 1995;58:294-298 Oct 95 " Time 11 Mar 1996:60 Apr 96 " Lancet 24 Feb 1996:527 Apr 96 " Ann Neur 1996;39:378-381 Apr 96 " Neur 1996;46:1275-1284 Jun 96 SPECT, diagnosis by Neur 1996;46:278-285 Apr 96 " Neur 1996;46:231-237 Apr 96 " Brain 1997;120:103-110 Apr 97 " J Neur N'surg Psych 1997;62:133-140 Apr 97 Speech therapy Neur 1996;47:1496-1504 Feb 97 Stem cells, cultured Science News 19 Jul 97:36 Aug 97 " , review of Science 4 Apr 1997:66-71 May 97 Stereotactic J Neurosurg 1995;83:197-205 Aug 95 " Science News 30 Mar 1996:204 Apr 96 Stimulation, chronic Neur 1996;46:1150-1153 Jun 96 " Arch Neur 1996;53:898-903 Oct 96 " Neur 1997;49:1078-1083 Nov 97 Strategy, summary Clin Neuropharm 1997;20:95-115 May 97 Strength, arm Ann Neur 1996;39:79-88 Mar 96 " Brain 1997;120:401-408 Jun 97 Striatonigral degener- Neur 1996;47:1032-1036 Nov 96 Stroke, help from Mov Disord 1997;12:124-126 Feb 97 " , adverse effect J Neur N'surg Psych 1997;62:288-289 Apr 97 " , " Neur 1997;49:707-710 Oct 97 " , " Nat Med 1997;3:1129-1132 Nov 97 Surgery, summary J Neur N'surg Psych 1997;62:2-8 Mar 97 Swallowing Neur 1997;48:373-375 Mar 97 " Mov Disord 1977;12:322-327 Aug 97 Sweats, control of Ann Neur 1995;37:120-122 Mar 95 Symmetrel (Amantadine) Neur 1996;46:1551-1556 Jul 96 Tachyphemia Mov Disord 1997;12:302-305 Aug 97 Tacrine, PD symptoms J Neur N'surg Psych 1996;61:324-325 Oct 96 Tactile acuity Neur 1997;49:168-177 Aug 97 Tardive dyskinesia Mov Disord 1997;12:119-121 Feb 97 " " , and PVP Lancet 15 Mar 1997:777 Apr 97 Terguride Clin Neuropharm 1996;19(1):72-80 Dec 97 Tetanus shot caused J Neur N'surg Psych 1997;63:258 Oct 97 Thalamotomy J Neur N'surg Psych 1996;60:564-571 Jun 96 " Brain 1996;119:1717-27 Jan 97 " Ann Neur 1997;41:108-111 Mar 97 Thalamus, and tremor Neur 1996;46:75-79 Mar 96 " Neur 1996;46:1150-1153 Jun 96 Therapy, tutorial Western J Med 1994;161:303-308 Jul 96 " Postgrad Med 1996;99:52-68 Jul 96 " Sci Amer Medicine Part 11, Chap XV Dec 97 Time, judgement of Science News 17 Feb 1996:101 Mar 96 " Brain 1996;119:51-70 May 96 Tolcapone Neur 1997;48:81-87 Feb 97 " Lancet 6 Sep 1997:712 Oct 97 " J Neur N'surg Psych 1997;63:421-428 Nov 97 " Neur 1997;1066-1071 Nov 97 Tourette Syndrome Mov Disord 1997:12:402-407 Aug 97 Toxins, Environmental Ann Neur 1994;36:765-770 Dec 94 " Neur 1995;45:435-439 Apr 95 " Neur 1995'45:2112 Feb 96 " Neur 1997;48:1583-1588 Jul 97 Tracking, visual Brain 1995;118:485-493 Jul 95 Transcranial mag. stim J Neurosci 1997;17:3178-3184 May 97 " Mov Disord 1997;12:315-321 Aug 97 Tremor, resting PD Neur 1996;46:1359-1370 Jun 96 ", cerebellar J Neur N'surg Psych 1997;62:282-284 Apr 97 ", surgery for J Neurosurg 1997;86:642-647 May 97 Ubiquitin Brain 1995;118:1447-49 Feb 96 Urinary dysfunction J Neur N'surg Psych 1997;62:507-511 Jul 97 " " Mov Disord 1997;12:509-513 Sep 97 Valproate Neur 1996;47:626-635 Oct 96 Visual perception Brain 1996;119:79-87 May 96 Vision abnormality Neur 1995;45:1144-1148 Oct 95 Visuospatial attention Brain 1995;118:153-166 Jun 95 Weight loss Neur 1997;48:88-91 Feb 97 Wine and dementia BMJ 5 Apr 97:997 May 97 Young onset Neur 1996;47:225-230 Sep 96 " " Mov Disord 1997;12:277-284 Aug 97 Zolpidem Lancet 26 Apr 97:1222-23 Jun 97 " Lancet 5 Jul 97:74 Aug 97 J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013